266 related articles for article (PubMed ID: 10866867)
1. HMG-CoA reductase inhibitors and the risk of fractures.
Meier CR; Schlienger RG; Kraenzlin ME; Schlegel B; Jick H
JAMA; 2000 Jun; 283(24):3205-10. PubMed ID: 10866867
[TBL] [Abstract][Full Text] [Related]
2. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients.
Wang PS; Solomon DH; Mogun H; Avorn J
JAMA; 2000 Jun; 283(24):3211-6. PubMed ID: 10866868
[TBL] [Abstract][Full Text] [Related]
3. Use of statins and risk of fractures.
van Staa TP; Wegman S; de Vries F; Leufkens B; Cooper C
JAMA; 2001 Apr; 285(14):1850-5. PubMed ID: 11308398
[TBL] [Abstract][Full Text] [Related]
4. Statins and the risk of dementia.
Jick H; Zornberg GL; Jick SS; Seshadri S; Drachman DA
Lancet; 2000 Nov; 356(9242):1627-31. PubMed ID: 11089820
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women.
Chan KA; Andrade SE; Boles M; Buist DS; Chase GA; Donahue JG; Goodman MJ; Gurwitz JH; LaCroix AZ; Platt R
Lancet; 2000 Jun; 355(9222):2185-8. PubMed ID: 10881890
[TBL] [Abstract][Full Text] [Related]
6. Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.
Rejnmark L; Vestergaard P; Mosekilde L
Calcif Tissue Int; 2006 Jul; 79(1):27-36. PubMed ID: 16868664
[TBL] [Abstract][Full Text] [Related]
7. Statin use and risk of gallstone disease followed by cholecystectomy.
Bodmer M; Brauchli YB; Krähenbühl S; Jick SS; Meier CR
JAMA; 2009 Nov; 302(18):2001-7. PubMed ID: 19903921
[TBL] [Abstract][Full Text] [Related]
8. Use of statins and the risk of Parkinson's disease: a retrospective case-control study in the UK.
Becker C; Jick SS; Meier CR
Drug Saf; 2008; 31(5):399-407. PubMed ID: 18422380
[TBL] [Abstract][Full Text] [Related]
9. HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis.
Ramcharan AS; Van Stralen KJ; Snoep JD; Mantel-Teeuwisse AK; Rosendaal FR; Doggen CJ
J Thromb Haemost; 2009 Apr; 7(4):514-20. PubMed ID: 19036068
[TBL] [Abstract][Full Text] [Related]
10. Is exposure to HMG-CoA reductase inhibitors (statins), fibrates, or other lipid-lowering drugs associated with reduced risk of bone fracture in older patients?
Douglas LO
J Fam Pract; 2000 Sep; 49(9):849-50. PubMed ID: 11032211
[No Abstract] [Full Text] [Related]
11. Risk of cataract in patients treated with statins.
Schlienger RG; Haefeli WE; Jick H; Meier CR
Arch Intern Med; 2001 Sep; 161(16):2021-6. PubMed ID: 11525705
[TBL] [Abstract][Full Text] [Related]
12. Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials.
Bauer DC; Mundy GR; Jamal SA; Black DM; Cauley JA; Ensrud KE; van der Klift M; Pols HA
Arch Intern Med; 2004 Jan; 164(2):146-52. PubMed ID: 14744837
[TBL] [Abstract][Full Text] [Related]
13. Do statins prevent both cardiovascular disease and fracture?
Cummings SR; Bauer DC
JAMA; 2000 Jun; 283(24):3255-7. PubMed ID: 10866875
[No Abstract] [Full Text] [Related]
14. Hydroxymethylglutaryl-coenzyme A reductase inhibitors in osteoporosis management.
Coons JC
Ann Pharmacother; 2002 Feb; 36(2):326-30. PubMed ID: 11847956
[TBL] [Abstract][Full Text] [Related]
15. Lipid lowering drugs prescription and the risk of peripheral neuropathy: an exploratory case-control study using automated databases.
Corrao G; Zambon A; Bertù L; Botteri E; Leoni O; Contiero P
J Epidemiol Community Health; 2004 Dec; 58(12):1047-51. PubMed ID: 15547071
[TBL] [Abstract][Full Text] [Related]
16. Lipid-lowering agents and the risk of hip fracture in a Medicaid population.
Ray WA; Daugherty JR; Griffin MR
Inj Prev; 2002 Dec; 8(4):276-9. PubMed ID: 12460961
[TBL] [Abstract][Full Text] [Related]
17. Statins and the risk of pneumonia: a population-based, nested case-control study.
Schlienger RG; Fedson DS; Jick SS; Jick H; Meier CR
Pharmacotherapy; 2007 Mar; 27(3):325-32. PubMed ID: 17316144
[TBL] [Abstract][Full Text] [Related]
18. [Inhibitors of HMG-CoA reductase in prevention of osteoporosis and bone fractures. Similar mechanism of action of statins and bisphosphonates].
Stajszczyk M; Mykała-Cieśla J
Pol Arch Med Wewn; 2002 Jan; 107(1):85-91. PubMed ID: 12046350
[No Abstract] [Full Text] [Related]
19. Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease.
Reid IR; Hague W; Emberson J; Baker J; Tonkin A; Hunt D; MacMahon S; Sharpe N
Lancet; 2001 Feb; 357(9255):509-12. PubMed ID: 11229669
[TBL] [Abstract][Full Text] [Related]
20. HMG-CoA reductase inhibitors and the risk of vertebral fracture.
Schoofs MW; Sturkenboom MC; van der Klift M; Hofman A; Pols HA; Stricker BH
J Bone Miner Res; 2004 Sep; 19(9):1525-30. PubMed ID: 15312254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
